Abzena

Abzena is a biotech company in San Diego, United States, founded in 2001. It has raised $75.0M across 2 rounds, most recently a $65.0M Growth Equity in March 2022.

Moving medicine forward

Employees
501–1000
Founded
2001
Business Model
B2B
Website
abzena.com
Total Funding
$75.0M
Last Round
$65.0M Growth EquityMar 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Abzena partners with biotechnology and pharmaceutical innovators to advance complex biologic and bioconjugate medicines from discovery through development and manufacturing. Its integrated capabilities include cell line development, bioconjugation, process development, and GMP manufacturing. Scientific teams work across early research, candidate selection, process development, and manufacturing to identify challenges early and reduce development risk.

Summary

It lists 501–1000 employees. It has raised $75.0M in total across 2 rounds, most recently a $65.0M Growth Equity round in Mar 2022. Investors include Biospring Partners and Welsh, Carson, Anderson & Stowe.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Growth EquityGrowth EquityMar 2022
$65.0M

Sign up to see all 2 events

Funding: Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$821.8MSep 2025
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Artificial Intelligence, Biotech
Series CTotal funding$630.0MJul 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Abzena on Indexed.vc
<a href="https://indexed.vc/companies/abzena"><img src="https://indexed.vc/api/badge/company/abzena" alt="Abzena on Indexed.vc" width="260" height="76" /></a>